October 19, 2025

Hold onto your hats, India has just made an exciting leap in medical science! Union Minister Jitendra Singh proudly announced the development of Nafithromycin – India’s FIRST domestic antibiotic specially designed to fight stubborn respiratory infections. This new antibiotic is a game-changer, especially useful for cancer patients and diabetics with weak immune systems. And guess what? Nafithromycin is not just any medicine; it’s the first molecule to be fully thought out, developed, and clinically tested right here in India. Talk about echoing the spirit of 'Make in India'! The Ministry of Science and Technology revealed that this magical medicine was developed by the Department of Biotechnology, teaming up with the renowned private pharma company Wockhardt. This team-up shows how private companies and government research can join hands to boost India’s biopharma sector. During the grand inauguration of the 3-day Medical Workshop focused on Artificial Intelligence, Jitendra Singh highlighted that India’s path to global scientific fame depends on building self-sustaining innovation hubs with strong private sector support. He said, “Most countries known for science achieved it by involving private companies and creating innovation ecosystems.” And there is more exciting news! India has scored a major WIN in gene therapy, especially for Haemophilia treatment. The first-ever indigenous clinical trial backed by the Department of Biotechnology took place at the Christian Medical College in Vellore. The results were jaw-dropping – a 60-70% correction rate with NO bleeding episodes! These findings have even got a spotlight in the famous New England Journal of Medicine, showing India is growing strong in cutting-edge medical research. But Mr. Singh didn’t stop there. He shared that India has already sequenced over 10,000 human genomes and plans to reach a whopping one million soon. That’s a huge step to understand health and diseases better than ever before. The Minister also talked about the Anusandhan National Research Foundation (ANRF), a Rs 50,000 crore fund over five years, with Rs 36,000 crore coming from private sources. This fund shows how India is changing the way it supports research – a big shout-out to better government-private teamwork! AI is another hot hero in this story. Singh pointed out that AI is transforming healthcare, governance, and decision-making. AI-powered mobile clinics are already working in rural areas, bringing quality healthcare where it’s most needed. The AI-based grievance system from DARPG handles complaints with a whopping 97-98% weekly disposal rate! Institutions like Sir Ganga Ram Hospital are mixing AI, biotechnology, and genomics to improve healthcare further. “We need more teamwork between government, private hospitals, and researchers to build Viksit Bharat @2047,” Singh said passionately. The message is loud and clear: India is entering a new age of self-reliance in biotechnology, AI, and genomic medicine. The mix of innovation, partnership, and care will take India to the very top of the global science and tech world. The event also saw participation from top minds like Shiv Kumar Kalyanaraman, CEO of ANRF, NK Ganguly, DS Rana, and Ajay Swaroop. Truly, India’s health future shines brighter than ever!

Read More at News →

Tags: Nafithromycin, Antibiotic, Gene therapy, Haemophilia, Jitendra singh, India biotech,